1. Home
  2. EVEX vs YDES Comparison

EVEX vs YDES Comparison

Compare EVEX & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eve Holding Inc.

EVEX

Eve Holding Inc.

HOLD

Current Price

$5.04

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

YDES

YD Bio Limited Ordinary Shares

N/A

Current Price

$13.05

Market Cap

1.1B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
EVEX
YDES
Founded
2020
2013
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Aerospace
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EVEX
YDES
Price
$5.04
$13.05
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$6.88
N/A
AVG Volume (30 Days)
1.4M
92.1K
Earning Date
11-04-2025
09-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$510,360.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
45.76
52 Week Low
$2.83
$5.30
52 Week High
$7.70
$31.00

Technical Indicators

Market Signals
Indicator
EVEX
YDES
Relative Strength Index (RSI) 69.92 N/A
Support Level $3.65 N/A
Resistance Level $3.85 N/A
Average True Range (ATR) 0.28 0.00
MACD 0.14 0.00
Stochastic Oscillator 96.27 0.00

Price Performance

Historical Comparison
EVEX
YDES

About EVEX Eve Holding Inc.

Eve Holding Inc is a provider of Urban Air Mobility solutions. The company's operating segments are; eVTOL that includes; the design and production of electric vertical take-off and landing vehicles (eVTOLs) including fixed wing and helicopter operators, as well as lessors that purchase and manage aircraft on behalf of operators; Service and Operations Solutions segment which includes a portfolio of maintenance and support services focused on its and third-party eVTOLs; and the UATM segment , a new Urban Air Traffic Management system designed to allow eVTOLs to operate safely and efficiently in dense urban airspace alongside conventional aircraft and drones.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: